TARS
#1683
Tarsus Pharmaceuticals, Inc. - Common Stock
71.6 5 USD
0.00%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-0.38%
Monthly Change
+21.94%
6 month change
-2.66%
Year Change
+8.46%
Previous Close
71.9 2
Open
71.7 4
Low
71.6 0
High
71.8 9
Volume
100
Financials
- Market Capitalization 3.14 B
- Employee 370
- Founded 2016
- CEO N/A
- Website www.tarsusrx.com
- Headquarter Delaware, United States
- FIGI BBG00RB9BNQ7
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-51.5
Price to sales ratio
7.58
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 1633 |  QURE uniQure N.V. - Ordinary Shares | 49.00 USD | -1.13% | +0.78% | +28.37% | +201.72% | 3.40 B USD | ||
| 1639 |  GPCR Structure Therapeutics Inc - American Depositary Shares | 47.35 USD | -3.80% | -5.94% | +0.53% | +77.08% | 3.38 B USD | ||
| 1689 |  IMNM Immunome, Inc. - Common Stock | 27.60 USD | -4.40% | -4.03% | +18.56% | +179.07% | 3.13 B USD | ||
| 1692 |  CLDX Celldex Therapeutics, Inc. - Common Stock | 39.82 USD | -1.58% | -2.04% | +11.92% | +46.18% | 3.13 B USD |
Frequently asked questions about Tarsus Pharmaceuticals, Inc. Common Stock
What is the Tarsus Pharmaceuticals, Inc. Common Stock stock price today?
The current price of Tarsus Pharmaceuticals, Inc. Common Stock (TARS) is 71.65. Over the past 24 hours, the stock has changed by -0.38%. Follow the TARS chart for real-time price dynamics.
What is the stock ticker of Tarsus Pharmaceuticals, Inc. Common Stock?
Tarsus Pharmaceuticals, Inc. Common Stock trades under the ticker TARS. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Tarsus Pharmaceuticals, Inc. Common Stock stock going up?
TARS has changed by -1.19% over the last week, +21.94% over the last month, and +8.46% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Tarsus Pharmaceuticals, Inc. Common Stock?
Tarsus Pharmaceuticals, Inc. Common Stock currently has a market capitalization of 3.14 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Tarsus Pharmaceuticals, Inc. Common Stock earnings last quarter?
Last quarter, Tarsus Pharmaceuticals, Inc. Common Stock reported earnings of -0.43 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Tarsus Pharmaceuticals, Inc. Common Stock revenue for the last quarter?
Tarsus Pharmaceuticals, Inc. Common Stock reported quarterly revenue of 173.91 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Tarsus Pharmaceuticals, Inc. Common Stock net income for the last quarter?
Tarsus Pharmaceuticals, Inc. Common Stock reported net income of -18.55 M for the last quarter. The previous quarter showed -6.97 M, which means net income changed by -166.27%.
How many employees does Tarsus Pharmaceuticals, Inc. Common Stock have?
As of the latest available data, Tarsus Pharmaceuticals, Inc. Common Stock has 370 employees. Workforce size can provide additional context about the company's scale and operations.
What is Tarsus Pharmaceuticals, Inc. Common Stock EBITDA?
Tarsus Pharmaceuticals, Inc. Common Stock EBITDA is -19.5 M, and its EBITDA margin is -11.21%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Tarsus Pharmaceuticals, Inc. Common Stock stock?
You can buy Tarsus Pharmaceuticals, Inc. Common Stock (TARS) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Tarsus Pharmaceuticals, Inc. Common Stock stock?
Investing in Tarsus Pharmaceuticals, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the TARS chart and related analysis on metatrader.com as part of your research.